| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.70▼ | 1.70▼ | 1.69▼ | 1.68▲ | 1.40▲ |
| MA10 | 1.71▼ | 1.69▼ | 1.70▼ | 1.62▲ | 0.87▲ |
| MA20 | 1.70▼ | 1.71▼ | 1.67▲ | 1.24▲ | 0.60▲ |
| MA50 | 1.69▼ | 1.66▲ | 1.66▲ | 0.68▲ | 1.04▲ |
| MA100 | 1.70▼ | 1.66▲ | 1.40▲ | 0.52▲ | 2.10▼ |
| MA200 | 1.67▲ | 1.35▲ | 0.99▲ | 0.90▲ | 2.28▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.002▼ | -0.003▼ | -0.001▼ | 0.024▲ | 0.210▲ |
| RSI | 40.023▼ | 48.608▼ | 50.924▲ | 73.004▲ | 72.325▲ |
| STOCH | 52.996 | 66.530 | 51.733 | 79.080 | 87.743▲ |
| WILL %R | -100.000▼ | -56.000 | -44.000 | -15.770▲ | -11.176▲ |
| CCI | -112.804▼ | 10.294 | -5.932 | 64.192 | 141.681▲ |
|
Monday, June 29, 2026 05:17 AM
Outlook Therapeutics, Inc. (Nasdaq: OTLK) (the Company), a late clinical-stage biopharmaceutical company working to develop the first.
|
|
Tuesday, June 16, 2026 05:39 AM
Prescription Drug User Fee Act (PDUFA) goal date of July 29, 2026ISELIN, N.J., June 16, 2026 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on ...
|
|
Saturday, June 06, 2026 08:49 PM
Track conference calls, annual meetings, summits, analyst days and other corporate events scheduled for Outlook Therapeutics Inc. Use the full market events calendar to scan activity across all ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 29/06/26 | 1.72 | 1.77 | 1.62 | 1.69 | 7,734,040 |
| 26/06/26 | 1.54 | 1.79 | 1.5302 | 1.71 | 11,106,514 |
| 25/06/26 | 1.66 | 1.7202 | 1.54 | 1.61 | 9,011,736 |
| 24/06/26 | 1.73 | 1.77 | 1.595 | 1.68 | 8,498,362 |
| 23/06/26 | 1.74 | 1.87 | 1.69 | 1.70 | 10,671,256 |
| 22/06/26 | 1.58 | 1.88 | 1.47 | 1.83 | 17,619,765 |
| 18/06/26 | 1.64 | 1.66 | 1.40 | 1.58 | 19,757,786 |
| 17/06/26 | 1.59 | 1.70 | 1.50 | 1.65 | 24,355,141 |
| 16/06/26 | 1.1944 | 1.575 | 1.175 | 1.57 | 41,294,902 |
| 15/06/26 | 1.32 | 1.40 | 1.13 | 1.16 | 23,196,698 |
|
|
||||
|
|
||||
|
|